How to Buy wockpharma Shares on Fincept?
You can buy Wockhardt Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Wockhardt Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Wockpharma, including updates on board meetings and corporate actions.
Wockhardt Limited - https://www.wockhardt.com
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company provides contract manufacturing services. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Wockhardt Limited Share Price Today
1,326.00
OPEN
1,349.40
HIGH
1,278.25
LOW
1,288.10
CLOSE
340 K
VOLUME
23,413 Cr
Market Cap
484507
Average Volume
Healthcare
Sector
NSI
Exchange
Wockhardt Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: WOCKPHARMA Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Wockhardt Limited |
WOCKPHARMA |
INE049B01025 |
Annual General Meeting |
21 Jun 2024 |
5 |
N/A |
Wockhardt Limited |
WOCKPHARMA |
INE049B01025 |
Annual General Meeting |
07 Aug 2023 |
5 |
N/A |
Wockhardt Limited |
WOCKPHARMA |
INE049B01025 |
Rights 3:10@ Premium Rs 220 Per Share |
08 Mar 2022 |
5 |
N/A |
Wockhardt Limited |
WOCKPHARMA |
INE049B01025 |
Annual General Meeting |
23 Jul 2021 |
5 |
N/A |
Wockhardt Limited |
WOCKPHARMA |
INE049B01025 |
Annual General Meeting |
24 Jul 2020 |
5 |
N/A |
NSE: WOCKPHARMA Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
WOCKPHARMA |
02 Jan 2025, 19:16:23 |
Press Release |
Pharmaceuticals |
WOCKPHARMA |
26 Dec 2024, 17:05:20 |
Trading Window-XBRL |
Pharmaceuticals |
WOCKPHARMA |
26 Dec 2024, 17:02:28 |
Trading Window |
Pharmaceuticals |
WOCKPHARMA |
16 Dec 2024, 09:06:24 |
Press Release |
Pharmaceuticals |
WOCKPHARMA |
27 Nov 2024, 16:43:10 |
Loss/Duplicate-Share Certificate-XBRL |
Pharmaceuticals |
NSE: WOCKPHARMA Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Wockhardt Limited |
WOCKPHARMA |
18 Oct 2024, 19:05:00 |
18 Oct 2024, 19:05:00 |
|
Wockhardt Limited |
WOCKPHARMA |
19 Jul 2024, 14:43:00 |
19 Jul 2024, 14:43:00 |
|
Wockhardt Limited |
WOCKPHARMA |
19 Apr 2024, 16:08:00 |
19 Apr 2024, 16:30:00 |
|
Wockhardt Limited |
WOCKPHARMA |
24 May 2024, 18:01:00 |
24 May 2024, 18:02:00 |
|
Wockhardt Limited |
WOCKPHARMA |
19 Oct 2023, 17:45:00 |
19 Oct 2023, 18:15:00 |
NSE: WOCKPHARMA Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director |
22 Sep 1942 |
08 Jul 1999 |
00045608 |
Habil Fakhruddin Khorakiwala |
Active |
Executive Director |
04 Nov 1970 |
29 Jun 2009 |
02191870 |
Huzaifa Habil Khorakiwala |
Active |
Executive Director-MD |
07 Sep 1972 |
29 Jun 2009 |
00102650 |
Murtaza Habil Khorakiwala |
Active |
Independent Director |
22 Nov 1953 |
30 Sep 2014 |
05009664 |
Tasneem Mehta |
Active |
Independent Director |
27 Dec 1958 |
10 Nov 2016 |
00391684 |
Vinesh Kumar Jairath |
Active |
NSE: WOCKPHARMA Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
WOCKPHARMA |
N/A |
INE049B01025 |
Wockhardt Limited |
08 Nov 2024, 15:48:08 |
WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 09-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
WOCKPHARMA |
N/A |
INE049B01025 |
Wockhardt Limited |
05 Aug 2024, 13:59:16 |
Financial Results/Fund Raising |
WOCKPHARMA |
N/A |
INE049B01025 |
Wockhardt Limited |
21 May 2024, 17:09:08 |
Fund Raising |
WOCKPHARMA |
N/A |
INE049B01025 |
Wockhardt Limited |
20 Mar 2024, 22:18:03 |
WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
WOCKPHARMA |
N/A |
INE049B01025 |
Wockhardt Limited |
05 Feb 2024, 16:29:03 |
NSE: WOCKPHARMA Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
WOCKPHARMA |
- |
INE049B01025 |
Wockhardt Limited |
08 Nov 2024, 00:00:00 |
Intimation of the Meeting of Board of Directors of Wockhardt Limited |
Financial Results |
WOCKPHARMA |
- |
INE049B01025 |
Wockhardt Limited |
05 Aug 2024, 00:00:00 |
Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 9th August, 2024, inter-alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024. |
Financial Results/Fund Raising |
WOCKPHARMA |
- |
INE049B01025 |
Wockhardt Limited |
21 May 2024, 00:00:00 |
Intimation of the meeting of Board of Directors of Wockhardt Limited |
Fund Raising |
WOCKPHARMA |
- |
INE049B01025 |
Wockhardt Limited |
20 Mar 2024, 00:00:00 |
Prior intimation of the meeting of Capital Raising Committee of the Company for determination of Issue Price. |
Financial Results |
WOCKPHARMA |
- |
INE049B01025 |
Wockhardt Limited |
05 Feb 2024, 00:00:00 |
Intimation of the Meeting of Board of Directors of Wockhardt Limited |
NSE: WOCKPHARMA Balance Sheet Data In (Cr)
| date | period_type | Treasury Shares Number | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Tradeand Other Payables Non Current | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Work In Process | Raw Materials | Other Receivables | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 0.00 | 153,409,546.00 | 153,409,546.00 | 20,110,000,000.00 | 23,430,000,000.00 | 9,470,000,000.00 | 55,490,000,000.00 | -3,720,000,000.00 | 9,470,000,000.00 | 1,890,000,000.00 | 33,950,000,000.00 | 46,140,000,000.00 | 37,130,000,000.00 | 3,180,000,000.00 | 33,950,000,000.00 | 33,180,000,000.00 | 0.00 | 0.00 | 770,000,000.00 | 770,000,000.00 | 38,750,000,000.00 | 14,950,000,000.00 | 700,000,000.00 | 0.00 | 0.00 | 0.00 | 530,000,000.00 | 13,420,000,000.00 | 1,230,000,000.00 | 12,190,000,000.00 | 300,000,000.00 | 23,800,000,000.00 | 1,450,000,000.00 | 10,010,000,000.00 | 660,000,000.00 | 9,350,000,000.00 | 0.00 | 490,000,000.00 | 6,870,000,000.00 | 0.00 | 0.00 | 100,000,000.00 | 6,770,000,000.00 | 75,880,000,000.00 | 55,800,000,000.00 | 1,120,000,000.00 | 0.00 | 5,880,000,000.00 | 660,000,000.00 | 660,000,000.00 | 0.00 | 24,480,000,000.00 | 14,570,000,000.00 | 9,910,000,000.00 | 22,870,000,000.00 | 0.00 | 22,870,000,000.00 | 4,810,000,000.00 | 18,060,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20,080,000,000.00 | 2,940,000,000.00 | 1,040,000,000.00 | 0.00 | 0.00 | 6,570,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6,950,000,000.00 | 0.00 | 0.00 | 2,580,000,000.00 | 1,150,000,000.00 | 1,430,000,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 0.00 | 153,400,936.00 | 153,400,936.00 | 16,070,000,000.00 | 23,560,000,000.00 | 10,650,000,000.00 | 54,710,000,000.00 | -6,070,000,000.00 | 10,650,000,000.00 | 2,440,000,000.00 | 33,590,000,000.00 | 42,500,000,000.00 | 36,620,000,000.00 | 3,030,000,000.00 | 33,590,000,000.00 | 130,000,000.00 | 2,400,000,000.00 | 20,800,000,000.00 | 770,000,000.00 | 770,000,000.00 | 39,870,000,000.00 | 11,960,000,000.00 | 720,000,000.00 | 280,000,000.00 | 0.00 | 720,000,000.00 | 350,000,000.00 | 10,610,000,000.00 | 1,700,000,000.00 | 8,910,000,000.00 | 280,000,000.00 | 27,910,000,000.00 | 130,000,000.00 | 12,950,000,000.00 | 740,000,000.00 | 12,210,000,000.00 | 410,000,000.00 | 390,000,000.00 | 9,620,000,000.00 | 1,860,000,000.00 | 0.00 | 100,000,000.00 | 7,660,000,000.00 | 76,490,000,000.00 | 54,650,000,000.00 | 1,010,000,000.00 | 1,400,000,000.00 | 5,790,000,000.00 | 0.00 | 650,000,000.00 | 0.00 | 22,940,000,000.00 | 13,410,000,000.00 | 9,530,000,000.00 | 23,180,000,000.00 | -23,760,000,000.00 | 46,940,000,000.00 | 4,430,000,000.00 | 950,000,000.00 | 28,010,000,000.00 | 10,930,000,000.00 | 2,620,000,000.00 | 0.00 | 21,840,000,000.00 | 2,680,000,000.00 | 1,110,000,000.00 | 240,000,000.00 | 2,680,000,000.00 | 6,400,000,000.00 | 2,830,000,000.00 | 490,000,000.00 | 3,080,000,000.00 | 180,000,000.00 | 6,180,000,000.00 | -1,580,000,000.00 | 7,760,000,000.00 | 5,050,000,000.00 | 420,000,000.00 | 5,050,000,000.00 | 0.00 | 5,050,000,000.00 |
| 2024-03-31T00:00:00 | annual | 0.00 | 153,400,936.00 | 153,400,936.00 | 16,070,000,000.00 | 23,560,000,000.00 | 10,650,000,000.00 | 54,710,000,000.00 | -6,070,000,000.00 | 10,650,000,000.00 | 2,440,000,000.00 | 33,590,000,000.00 | 42,500,000,000.00 | 36,620,000,000.00 | 3,030,000,000.00 | 33,590,000,000.00 | 130,000,000.00 | 2,400,000,000.00 | 20,800,000,000.00 | 770,000,000.00 | 770,000,000.00 | 39,870,000,000.00 | 11,960,000,000.00 | 720,000,000.00 | 280,000,000.00 | 0.00 | 720,000,000.00 | 350,000,000.00 | 10,610,000,000.00 | 1,700,000,000.00 | 8,910,000,000.00 | 280,000,000.00 | 27,910,000,000.00 | 130,000,000.00 | 12,950,000,000.00 | 740,000,000.00 | 12,210,000,000.00 | 410,000,000.00 | 390,000,000.00 | 9,620,000,000.00 | 1,860,000,000.00 | 0.00 | 100,000,000.00 | 7,660,000,000.00 | 76,490,000,000.00 | 54,650,000,000.00 | 1,010,000,000.00 | 1,400,000,000.00 | 5,790,000,000.00 | 0.00 | 650,000,000.00 | 0.00 | 22,940,000,000.00 | 13,410,000,000.00 | 9,530,000,000.00 | 23,180,000,000.00 | -23,760,000,000.00 | 46,940,000,000.00 | 4,430,000,000.00 | 950,000,000.00 | 28,010,000,000.00 | 10,930,000,000.00 | 2,620,000,000.00 | 0.00 | 21,840,000,000.00 | 2,680,000,000.00 | 1,110,000,000.00 | 240,000,000.00 | 2,680,000,000.00 | 6,400,000,000.00 | 2,830,000,000.00 | 490,000,000.00 | 3,080,000,000.00 | 180,000,000.00 | 6,180,000,000.00 | -1,580,000,000.00 | 7,760,000,000.00 | 5,050,000,000.00 | 420,000,000.00 | 5,050,000,000.00 | 0.00 | 5,050,000,000.00 |
| 2023-09-30T00:00:00 | quarterly | 0.00 | 144,094,573.00 | 144,094,573.00 | 19,490,000,000.00 | 22,740,000,000.00 | 9,370,000,000.00 | 51,280,000,000.00 | -6,480,000,000.00 | 9,370,000,000.00 | 2,710,000,000.00 | 31,250,000,000.00 | 40,930,000,000.00 | 34,320,000,000.00 | 3,070,000,000.00 | 31,250,000,000.00 | 30,530,000,000.00 | 0.00 | 0.00 | 720,000,000.00 | 720,000,000.00 | 39,880,000,000.00 | 13,030,000,000.00 | 750,000,000.00 | 0.00 | 0.00 | 0.00 | 330,000,000.00 | 11,670,000,000.00 | 1,990,000,000.00 | 9,680,000,000.00 | 280,000,000.00 | 26,850,000,000.00 | 1,330,000,000.00 | 11,070,000,000.00 | 720,000,000.00 | 10,350,000,000.00 | 0.00 | 460,000,000.00 | 8,140,000,000.00 | 0.00 | 0.00 | 140,000,000.00 | 8,000,000,000.00 | 74,200,000,000.00 | 53,830,000,000.00 | 1,070,000,000.00 | 0.00 | 5,640,000,000.00 | 620,000,000.00 | 620,000,000.00 | 0.00 | 21,880,000,000.00 | 12,550,000,000.00 | 9,330,000,000.00 | 23,480,000,000.00 | 0.00 | 23,480,000,000.00 | 4,190,000,000.00 | 19,290,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20,370,000,000.00 | 2,750,000,000.00 | 2,980,000,000.00 | 0.00 | 0.00 | 6,350,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,140,000,000.00 | 0.00 | 0.00 | 1,150,000,000.00 | 610,000,000.00 | 540,000,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 0.00 | 144,088,323.00 | 144,088,323.00 | 17,970,000,000.00 | 21,840,000,000.00 | 12,090,000,000.00 | 52,410,000,000.00 | -12,270,000,000.00 | 12,090,000,000.00 | 2,970,000,000.00 | 33,540,000,000.00 | 35,780,000,000.00 | 36,620,000,000.00 | 3,080,000,000.00 | 33,540,000,000.00 | 160,000,000.00 | 7,100,000,000.00 | 16,180,000,000.00 | 720,000,000.00 | 720,000,000.00 | 40,210,000,000.00 | 5,860,000,000.00 | 780,000,000.00 | 260,000,000.00 | 0.00 | 780,000,000.00 | 320,000,000.00 | 4,500,000,000.00 | 2,260,000,000.00 | 2,240,000,000.00 | 260,000,000.00 | 34,350,000,000.00 | 130,000,000.00 | 17,340,000,000.00 | 710,000,000.00 | 16,630,000,000.00 | 520,000,000.00 | 440,000,000.00 | 11,980,000,000.00 | 3,090,000,000.00 | 0.00 | 220,000,000.00 | 8,670,000,000.00 | 76,830,000,000.00 | 54,750,000,000.00 | 1,070,000,000.00 | 1,420,000,000.00 | 6,080,000,000.00 | 0.00 | 640,000,000.00 | 0.00 | 21,450,000,000.00 | 12,000,000,000.00 | 9,450,000,000.00 | 24,480,000,000.00 | -22,020,000,000.00 | 46,500,000,000.00 | 4,260,000,000.00 | 1,030,000,000.00 | 27,670,000,000.00 | 10,880,000,000.00 | 2,660,000,000.00 | 0.00 | 22,080,000,000.00 | 3,090,000,000.00 | 2,940,000,000.00 | 340,000,000.00 | 3,090,000,000.00 | 6,580,000,000.00 | 2,620,000,000.00 | 540,000,000.00 | 3,420,000,000.00 | 260,000,000.00 | 7,970,000,000.00 | -1,130,000,000.00 | 9,100,000,000.00 | 900,000,000.00 | 600,000,000.00 | 900,000,000.00 | 0.00 | 900,000,000.00 |
| 2023-03-31T00:00:00 | annual | 0.00 | 144,088,323.00 | 144,088,323.00 | 17,970,000,000.00 | 21,840,000,000.00 | 12,090,000,000.00 | 52,410,000,000.00 | -12,270,000,000.00 | 12,090,000,000.00 | 2,970,000,000.00 | 33,540,000,000.00 | 35,780,000,000.00 | 36,620,000,000.00 | 3,080,000,000.00 | 33,540,000,000.00 | 160,000,000.00 | 7,100,000,000.00 | 16,180,000,000.00 | 720,000,000.00 | 720,000,000.00 | 40,210,000,000.00 | 5,860,000,000.00 | 780,000,000.00 | 260,000,000.00 | 0.00 | 780,000,000.00 | 320,000,000.00 | 4,500,000,000.00 | 2,260,000,000.00 | 2,240,000,000.00 | 260,000,000.00 | 34,350,000,000.00 | 130,000,000.00 | 17,340,000,000.00 | 710,000,000.00 | 16,630,000,000.00 | 520,000,000.00 | 440,000,000.00 | 11,980,000,000.00 | 3,090,000,000.00 | 0.00 | 220,000,000.00 | 8,670,000,000.00 | 76,830,000,000.00 | 54,750,000,000.00 | 1,070,000,000.00 | 1,420,000,000.00 | 6,080,000,000.00 | 0.00 | 640,000,000.00 | 0.00 | 21,450,000,000.00 | 12,000,000,000.00 | 9,450,000,000.00 | 24,480,000,000.00 | -22,020,000,000.00 | 46,500,000,000.00 | 4,260,000,000.00 | 1,030,000,000.00 | 27,670,000,000.00 | 10,880,000,000.00 | 2,660,000,000.00 | 0.00 | 22,080,000,000.00 | 3,090,000,000.00 | 2,940,000,000.00 | 340,000,000.00 | 3,090,000,000.00 | 6,580,000,000.00 | 2,620,000,000.00 | 540,000,000.00 | 3,420,000,000.00 | 260,000,000.00 | 7,970,000,000.00 | -1,130,000,000.00 | 9,100,000,000.00 | 900,000,000.00 | 600,000,000.00 | 900,000,000.00 | 0.00 | 900,000,000.00 |
| 2022-03-31T00:00:00 | annual | 0.00 | 144,060,153.00 | 144,060,153.00 | 14,920,000,000.00 | 21,980,000,000.00 | 19,050,000,000.00 | 57,110,000,000.00 | -6,180,000,000.00 | 19,050,000,000.00 | 3,360,000,000.00 | 38,490,000,000.00 | 42,040,000,000.00 | 42,020,000,000.00 | 3,530,000,000.00 | 38,490,000,000.00 | 180,000,000.00 | 12,760,000,000.00 | 16,150,000,000.00 | 720,000,000.00 | 720,000,000.00 | 40,410,000,000.00 | 8,340,000,000.00 | 0.00 | 320,000,000.00 | 1,520,000,000.00 | 0.00 | 280,000,000.00 | 6,220,000,000.00 | 2,670,000,000.00 | 3,550,000,000.00 | 320,000,000.00 | 32,070,000,000.00 | 140,000,000.00 | 15,760,000,000.00 | 690,000,000.00 | 15,070,000,000.00 | 660,000,000.00 | 370,000,000.00 | 11,330,000,000.00 | 1,940,000,000.00 | 0.00 | 180,000,000.00 | 9,210,000,000.00 | 82,430,000,000.00 | 56,540,000,000.00 | 1,030,000,000.00 | 1,370,000,000.00 | 5,730,000,000.00 | 0.00 | 620,000,000.00 | 0.00 | 19,440,000,000.00 | 10,530,000,000.00 | 8,910,000,000.00 | 28,700,000,000.00 | -21,310,000,000.00 | 50,010,000,000.00 | 3,990,000,000.00 | 970,000,000.00 | 29,610,000,000.00 | 11,860,000,000.00 | 3,580,000,000.00 | 0.00 | 25,890,000,000.00 | 3,400,000,000.00 | 1,440,000,000.00 | 360,000,000.00 | 2,900,000,000.00 | 7,690,000,000.00 | 3,520,000,000.00 | 490,000,000.00 | 3,680,000,000.00 | 620,000,000.00 | 9,180,000,000.00 | -1,130,000,000.00 | 10,310,000,000.00 | 3,700,000,000.00 | 80,000,000.00 | 3,700,000,000.00 | 0.00 | 3,700,000,000.00 |
| 2021-03-31T00:00:00 | annual | 0.00 | 120,215,608.00 | 120,215,608.00 | 21,000,000,000.00 | 26,740,000,000.00 | 15,680,000,000.00 | 57,080,000,000.00 | -6,960,000,000.00 | 15,680,000,000.00 | 3,420,000,000.00 | 33,760,000,000.00 | 38,790,000,000.00 | 37,590,000,000.00 | 3,830,000,000.00 | 33,760,000,000.00 | 280,000,000.00 | 15,290,000,000.00 | 8,940,000,000.00 | 550,000,000.00 | 550,000,000.00 | 40,150,000,000.00 | 8,940,000,000.00 | 0.00 | 840,000,000.00 | 0.00 | 0.00 | 280,000,000.00 | 7,820,000,000.00 | 2,790,000,000.00 | 5,030,000,000.00 | 0.00 | 31,210,000,000.00 | 140,000,000.00 | 18,920,000,000.00 | 630,000,000.00 | 18,290,000,000.00 | 1,140,000,000.00 | 600,000,000.00 | 9,360,000,000.00 | 1,690,000,000.00 | 20,000,000.00 | 690,000,000.00 | 6,960,000,000.00 | 77,740,000,000.00 | 53,490,000,000.00 | -4,400,000.00 | 1,050,000,000.00 | 3,980,000,000.00 | 4,500,000.00 | 452,700,000.00 | 4,500,000.00 | 18,080,000,000.00 | 9,040,000,000.00 | 9,040,000,000.00 | 29,204,400,000.00 | -19,141,300,000.00 | 48,345,700,000.00 | 6,090,000,000.00 | 944,100,000.00 | 27,059,100,000.00 | 10,699,600,000.00 | 3,552,900,000.00 | 0.00 | 24,250,000,000.00 | 2,385,900,000.00 | 1,440,000,000.00 | 560,000,000.00 | 2,390,000,000.00 | 7,990,000,000.00 | 4,360,000,000.00 | 450,000,000.00 | 3,180,000,000.00 | 330,000,000.00 | 9,180,000,000.00 | -1,570,000,000.00 | 10,750,000,000.00 | 2,360,000,000.00 | 40,000,000.00 | 2,320,000,000.00 | 0.00 | 2,320,000,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22,300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: WOCKPHARMA Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repurchase Of Capital Stock | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Preferred Stock Issuance | Preferred Stock Payments | Preferred Stock Issuance | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Net Business Purchase And Sale | Sale Of Business | Net Intangibles Purchase And Sale | Sale Of Intangibles | Purchase Of Intangibles | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 30,000,000.00 | 0.00 | -4,060,000,000.00 | 5,490,000,000.00 | 4,680,000,000.00 | -2,160,000,000.00 | 5,050,000,000.00 | 900,000,000.00 | -10,000,000.00 | 4,160,000,000.00 | 3,340,000,000.00 | 0.00 | -1,970,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,680,000,000.00 | 4,680,000,000.00 | 1,430,000,000.00 | 720,000,000.00 | -380,000,000.00 | 720,000,000.00 | 710,000,000.00 | -4,060,000,000.00 | 4,770,000,000.00 | -1,370,000,000.00 | 100,000,000.00 | 30,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,570,000,000.00 | 0.00 | -1,570,000,000.00 | 70,000,000.00 | 660,000,000.00 | -590,000,000.00 | 0.00 | 2,190,000,000.00 | -300,000,000.00 | -80,000,000.00 | -1,930,000,000.00 | 0.00 | 80,000,000.00 | 1,770,000,000.00 | 2,560,000,000.00 | 10,000,000.00 | 680,000,000.00 | 2,230,000,000.00 | 0.00 | 2,230,000,000.00 | -20,000,000.00 | 520,000,000.00 | 0.00 | -4,200,000,000.00 |
| 2023-03-31T00:00:00 | annual | -560,000,000.00 | 0.00 | -4,060,000,000.00 | 4,090,000,000.00 | 0.00 | -2,090,000,000.00 | 900,000,000.00 | 3,700,000,000.00 | 70,000,000.00 | -2,870,000,000.00 | -3,150,000,000.00 | 0.00 | -2,420,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30,000,000.00 | 810,000,000.00 | -1,160,000,000.00 | 810,000,000.00 | -780,000,000.00 | -4,060,000,000.00 | 3,280,000,000.00 | -1,250,000,000.00 | 30,000,000.00 | 20,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,670,000,000.00 | 0.00 | -1,670,000,000.00 | 370,000,000.00 | 790,000,000.00 | -420,000,000.00 | 0.00 | 1,530,000,000.00 | -110,000,000.00 | 1,530,000,000.00 | -2,050,000,000.00 | 0.00 | 1,410,000,000.00 | 2,170,000,000.00 | 2,950,000,000.00 | 10,000,000.00 | 720,000,000.00 | 2,510,000,000.00 | 240,000,000.00 | 2,270,000,000.00 | -800,000,000.00 | 590,000,000.00 | 0.00 | -6,240,000,000.00 |
| 2022-03-31T00:00:00 | annual | 2,010,000,000.00 | 0.00 | -20,880,000,000.00 | 16,340,000,000.00 | 7,480,000,000.00 | -2,120,000,000.00 | 3,700,000,000.00 | 2,320,000,000.00 | -30,000,000.00 | 1,410,000,000.00 | -710,000,000.00 | 0.00 | -1,900,000,000.00 | -20,000,000.00 | -20,000,000.00 | 0.00 | 0.00 | 0.00 | 7,480,000,000.00 | 7,480,000,000.00 | -5,550,000,000.00 | -1,010,000,000.00 | 0.00 | 0.00 | -4,540,000,000.00 | -20,880,000,000.00 | 16,340,000,000.00 | -2,010,000,000.00 | 70,000,000.00 | 30,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -940,000,000.00 | 0.00 | -940,000,000.00 | -1,170,000,000.00 | 10,000,000.00 | -1,180,000,000.00 | 0.00 | 4,130,000,000.00 | -970,000,000.00 | 3,670,000,000.00 | 4,570,000,000.00 | -140,000,000.00 | 300,000,000.00 | -1,060,000,000.00 | 2,910,000,000.00 | 10,000,000.00 | 200,000,000.00 | 2,470,000,000.00 | 0.00 | 2,470,000,000.00 | -110,000,000.00 | 60,000,000.00 | 0.00 | -4,110,000,000.00 |
| 2021-03-31T00:00:00 | annual | -4,530,000,000.00 | -3,540,000,000.00 | -9,550,000,000.00 | 4,100,000,000.00 | 0.00 | -1,660,000,000.00 | 2,320,000,000.00 | 2,190,000,000.00 | 10,000,000.00 | 120,000,000.00 | -11,710,000,000.00 | 0.00 | -2,350,000,000.00 | -10,000,000.00 | -5,300,000.00 | -3,540,000,000.00 | -3,540,000,000.00 | 0.00 | 0.00 | 0.00 | -5,160,000,000.00 | 290,000,000.00 | 0.00 | 0.00 | -5,450,000,000.00 | -9,550,000,000.00 | 4,100,000,000.00 | 14,700,000,000.00 | -100,000,000.00 | 140,000,000.00 | 0.00 | 0.00 | 15,350,000,000.00 | 15,350,000,000.00 | 110,000,000.00 | 960,000,000.00 | -850,000,000.00 | -800,000,000.00 | 10,000,000.00 | -810,000,000.00 | 0.00 | -2,870,000,000.00 | -1,170,000,000.00 | -1,430,000,000.00 | -2,770,000,000.00 | -100,000,000.00 | -1,070,000,000.00 | 2,510,000,000.00 | 2,130,000,000.00 | 20,000,000.00 | 70,000,000.00 | 2,460,000,000.00 | 0.00 | 2,460,000,000.00 | 20,000,000.00 | -850,000,000.00 | -14,700,000,000.00 | 9,160,000,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,200,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,723,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 49,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: WOCKPHARMA Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Discontinuous Operations | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Restructuring And Mergern Acquisition | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -43.50 | 0.00 | 239.00 | -145.00 | -145.00 | -463.00 | 223.00 | 1,165.00 | 94.00 | -129.00 | -299.00 | 291.00 | 6.00 | -361.50 | -463.00 | 2,819.00 | 36.00 | 14.43 | 14.43 | 0.00 | 0.00 | -463.00 | -463.00 | 0.00 | -463.00 | 9.00 | -472.00 | 0.00 | -472.00 | 52.00 | -420.00 | 52.00 | -145.00 | 66.00 | 79.00 | 0.00 | -299.00 | 14.00 | 291.00 | 6.00 | -30.00 | 1,654.00 | 567.00 | 223.00 | 0.00 | 223.00 | 230.00 | 125.00 | 105.00 | 36.00 | 1,624.00 | 1,165.00 | 2,789.00 | 2,789.00 |
| 2023-03-31T00:00:00 | annual | -1.28 | 0.00 | 185.00 | -266.00 | -266.00 | -559.00 | 251.00 | 1,111.00 | -81.00 | -332.00 | -298.00 | 292.00 | 4.00 | -294.28 | -559.00 | 2,795.00 | 34.00 | 14.41 | 14.41 | 0.00 | 0.00 | -559.00 | -559.00 | 0.00 | -559.00 | 62.00 | -621.00 | 0.00 | -621.00 | -3.00 | -624.00 | 9.00 | -266.00 | 253.00 | 0.00 | 13.00 | -298.00 | 10.00 | 292.00 | 4.00 | -149.00 | 1,684.00 | 522.00 | 251.00 | 24.00 | 227.00 | 244.00 | 134.00 | 110.00 | 34.00 | 1,535.00 | 1,111.00 | 2,646.00 | 2,646.00 |
| 2022-03-31T00:00:00 | annual | -58.56 | 0.00 | 301.00 | -183.00 | -183.00 | -244.00 | 247.00 | 1,267.00 | 118.00 | -129.00 | -293.00 | 282.00 | 6.00 | -119.56 | -244.00 | 3,159.00 | 31.00 | 12.10 | 12.06 | 0.00 | 0.00 | -244.00 | -244.00 | 0.00 | -244.00 | 35.00 | -279.00 | 0.00 | -279.00 | -132.00 | -411.00 | 3.00 | -183.00 | 183.00 | 0.00 | 0.00 | -293.00 | 17.00 | 282.00 | 6.00 | 51.00 | 1,892.00 | 556.00 | 247.00 | 19.00 | 247.00 | 328.00 | 180.00 | 148.00 | 31.00 | 1,943.00 | 1,267.00 | 3,210.00 | 3,210.00 |
| 2021-03-31T00:00:00 | annual | -35.50 | 0.00 | 63.00 | -142.00 | -142.00 | -299.00 | 246.00 | 1,135.00 | -79.00 | -325.00 | -228.00 | 243.00 | 21.00 | -192.50 | 686.00 | 3,006.00 | 30.00 | 12.06 | 12.01 | 0.00 | 0.00 | 686.00 | 686.00 | 0.00 | 686.00 | -2.00 | 688.00 | 985.00 | -297.00 | -271.00 | -568.00 | 111.00 | -142.00 | 142.00 | 168.22 | 0.00 | -228.00 | 6.00 | 243.00 | 21.00 | -307.00 | 1,871.00 | 573.00 | 246.00 | 19.00 | 227.00 | 267.00 | 132.00 | 135.00 | 30.00 | 1,564.00 | 1,135.00 | 2,699.00 | 2,699.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 94.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
-19.78
P/E
N/A
P/B
6.712987
Dividend Yield
N/A
Market Cap
23,413.03 Cr.
Face Value
214.666
Book Value
214.666
ROE
-11.73%
EBITDA Growth
207.75 Cr.
Debt/Equity
64.336
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of wockpharma?
The market capitalization of Wockhardt Limited is ₹23,413 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Wockhardt Limited?
The PE and PB ratios of Wockhardt Limited are Not Available and 6.712987 respectively as of 05 Feb 2025.
What is the 52 Week High of Wockhardt Limited?
The 52-week high of Wockhardt Limited is ₹1536.6 as of 05 Feb 2025.
What is the 52 Week Low of Wockhardt Limited?
The 52-week low of Wockhardt Limited is ₹402.65 as of 05 Feb 2025.
What are the earnings per share (EPS) for Wockhardt Limited?
The Earnings Per Share (EPS) of Wockhardt Limited is ₹-19.78 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Wockhardt Limited?
The Return on Equity (ROE) of Wockhardt Limited is -11.73% as per the most recent financial year data. Explore more on Fincept.